Bone mineral density (BMD) is the most widely used predictor of fracture risk. We performed
the largest meta-analysis to date on lumbar spine and femoral neck BMD, including 17 …

Objective: Asymptomatic primary hyperparathyroidism (PHPT) is routinely encountered in
clinical practices of endocrinology throughout the world. This report distills an update of current …

ROS are highly reactive molecules which consist of a number of diverse chemical species,
including radical and non-radical oxygen species. Oxidative stress occurs as a result of an …

The molecular mechanisms that regulate hADSC differentiation toward osteogenic precursors
and subsequent bone‐forming osteoblasts is unknown. Using osteoblast precursors …

This is a consensus statement from an international group, mostly of clinical endocrinologists.
MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH …

This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the …

… Maria Luisa Brandi, Department of Internal Medicine, University of Florence, Florence, Italy.
… Maria Luisa Brandi, Department of Internal Medicine, University of Florence, Florence, Italy. …

The purpose of this randomized, double-masked, placebo-controlled study was to
determine the efficacy and safety of risedronate in the prevention of vertebral fractures in …

Background Bisphosphonates are effective agents for the management of osteoporosis.
Their low bioavailability and low potency necessitate frequent administration on an empty …

Background Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin,
increases bone formation, and decreases bone resorption. Methods We enrolled 4093 …